Annovis Bio Inc
(ANVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Operating Expenses | 1,606 | 714 | 0 | 0 | 0 |
| Operating Income | -1,606 | -714 | N/A | N/A | N/A |
| Other Income | 615 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -991 | -714 | 0 | 0 | 0 |
| Net Income Continuous | -991 | -714 | N/A | N/A | N/A |
| Net Income | $-991 | $-714 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -3.51 | -2.57 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -3.50 | -2.57 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -3.51 | -2.57 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -3.50 | -2.57 | N/A | N/A | N/A |
| EBITDA(a) | $-1,601 | $-714 | $N/A | $N/A | $N/A |